Repeated Ultrasound-Guided Lumbar Sympathetic Block for Refractory Painful Diabetic Peripheral Neuropathy: The First Case from Mzuzu Central Hospital, Malawi
Malawi Medical Journal · 2026 · 38 (2) · 140-145
DOI: 10.4314/mmj.v38i2.12 ↗Kurz gefasst
Fallbericht in der Zeitschrift Malawi Medical Journal, 2026. Verfasst von Junyi Ren und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Baoji Central Hospital, Baoji, China. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Autonomic Nerve Block, Ultrasonography, Interventional, Neuralgia. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Painful diabetic peripheral neuropathy (PDPN) is a common complication of diabetes mellitus characterized by chronic neuropathic pain, sleep disturbance, and impaired quality of life. Although pharmacological therapies remain the cornerstone of treatment, many patients experience inadequate symptom control. Access to advanced interventional pain management techniques, including radiofrequency ablation and neuromodulation, remains limited in many healthcare settings. We report the first case ofultrasoundguided lumbar sympathetic block (LSB) performed for refractory PDPN at Mzuzu Central Hospital, Malawi.Case Presentation: A 19-year-old woman with a 9-year history of type 1 diabetes mellitus presented with bilateral lower-limb neuropathic pain that had persisted for 6 years and progressively worsened over the preceding 3 years. Symptoms were more severe in the right lower limb, with a baseline Numerical Rating Scale (NRS) score of 8/10. Clinical features included burning pain, stabbing pain, numbness, allodynia, sleep disturbance, and impaired mobility. The Douleur Neuropathique 4 (DN4) score was 8/10. Previous treatment with amitriptyline, gabapentin, vitamin B supplementation, diclofenac, and tramadol failed to provide satisfactory symptom relief.The patient underwent four ultrasound-guided right lumbar sympathetic blocks using 10 mL of 1% lidocaine between May 15 andMay 25, 2026. Pain intensity decreased from an NRS score of 8 to 4 immediately after the first procedure and from 5 to 1 after thesecond procedure. Complete pain relief was achieved before the third procedure and was maintained throughout the two-weekfollow-up period. Skin temperature increased by approximately 0.9–1.0°C after each block. No procedure-related complicationswere observed.
Conclusion
Repeated ultrasound-guided lumbar sympathetic block provided substantial and sustained pain relief in refractory PDPN. This minimally invasive, low-cost, and reproducible technique may represent a practical therapeutic option for selected patients withrefractory neuropathic pain and may be particularly valuable in settings where access to advanced pain interventions is limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Baoji Central Hospital, Baoji, China.
- Department of Anesthesiology, Mzuzu Central Hospital, Mzuzu, Malawi.
- Department of Endocrine, Xi'an Xidian Group Hospital, Xi'an, China.
- Department of Medicine, Mzuzu Central Hospital, Mzuzu, Malawi.
Zitieren
APA
Ren, J., Masoo, F., & Zhu, Y. (2026). Repeated Ultrasound-Guided Lumbar Sympathetic Block for Refractory Painful Diabetic Peripheral Neuropathy: The First Case from Mzuzu Central Hospital, Malawi. Malawi Medical Journal, 38(2), 140-145. https://doi.org/10.4314/mmj.v38i2.12
Vancouver
Ren J, Masoo F, Zhu Y. Repeated Ultrasound-Guided Lumbar Sympathetic Block for Refractory Painful Diabetic Peripheral Neuropathy: The First Case from Mzuzu Central Hospital, Malawi. Malawi Medical Journal. 2026;38(2):140-145. doi:10.4314/mmj.v38i2.12
BibTeX
@article{Ren2026,
author = {Ren, Junyi and Masoo, Francis and Zhu, Yingpu},
title = {Repeated Ultrasound-Guided Lumbar Sympathetic Block for Refractory Painful Diabetic Peripheral Neuropathy: The First Case from Mzuzu Central Hospital, Malawi},
journal = {Malawi Medical Journal},
year = {2026},
volume = {38},
number = {2},
pages = {140--145},
doi = {10.4314/mmj.v38i2.12}
}
EUVIMED